Boyd Group Services (BGSI) – Research Analysts’ Recent Ratings Updates
Boyd Group Services (NYSE: BGSI) has recently received a number of price target changes and ratings updates: 11/13/2026 – Boyd Group Services was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”. 11/12/2026 – Boyd Group Services was downgraded by Canadian Imperial Bank of Commerce from “strong-buy” to “hold”. 11/12/2026 – Boyd Group Services […]
Research Analysts’ Recent Ratings Updates for Paylocity (PCTY)
Several analysts have recently updated their ratings and price targets for Paylocity (NASDAQ: PCTY): 11/9/2026 – Paylocity had its price target raised by Citigroup from $208.00 to $214.00. They now have a “buy” rating on the stock. 11/7/2026 – Paylocity was upgraded by Wall Street Zen from “hold” to “buy”. 11/6/2026 – Paylocity had its […]
Recent Research Analysts’ Ratings Updates for Saputo (SAP)
Saputo (TSE: SAP) recently received a number of ratings updates from brokerages and research firms: 11/9/2026 – Saputo had its price target raised by Ventum from C$49.00 to C$50.00. They now have a “buy” rating on the stock. 11/9/2026 – Saputo had its price target raised by Desjardins from C$47.00 to C$49.00. They now have […]
Recent Research Analysts’ Ratings Updates for DT Midstream (DTM)
DT Midstream (NYSE: DTM) recently received a number of ratings updates from brokerages and research firms: 11/3/2026 – DT Midstream had its price target lowered by Morgan Stanley from $164.00 to $161.00. They now have an “overweight” rating on the stock. 11/3/2026 – DT Midstream had its price target lowered by Scotiabank from $165.00 to […]
Recent Analysts’ Ratings Updates for Bausch Health Cos (BHC)
A number of research firms have changed their ratings and price targets for Bausch Health Cos (NYSE: BHC): 11/5/2026 – Bausch Health Cos was downgraded by Zacks Research from “strong-buy” to “hold”. 10/29/2026 – Bausch Health Cos had its “sell (d)” rating reaffirmed by Weiss Ratings. 10/29/2026 – Bausch Health Cos had its price target […]
ACADIA Pharmaceuticals (ACAD) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for ACADIA Pharmaceuticals (NASDAQ: ACAD): 11/6/2026 – ACADIA Pharmaceuticals had its price target raised by Canaccord Genuity Group from $36.00 to $38.00. They now have a “buy” rating on the stock. 11/5/2026 – ACADIA Pharmaceuticals had its price target raised by Royal Bank […]
Analysts’ Recent Ratings Updates for Iambic Therapeutics (IAM)
Iambic Therapeutics (NASDAQ: IAM) recently received a number of ratings updates from brokerages and research firms: 11/10/2026 – Iambic Therapeutics is now covered by Jefferies Financial Group. They set a “buy” rating and a $35.00 price target on the stock. 11/9/2026 – Iambic Therapeutics is now covered by JPMorgan Chase & Co.. They set an […]
Citizens (CIZN) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Citizens (NASDAQ: CIZN) in the last few weeks: 11/9/2026 – Citizens was given a new $5.50 price target by Wells Fargo & Company. 11/9/2026 – Citizens had its “market outperform” rating reaffirmed by Citigroup. 11/4/2026 – Citizens had its “market perform” rating reaffirmed […]
Research Analysts’ Recent Ratings Updates for Transcat (TRNS)
Several analysts have recently updated their ratings and price targets for Transcat (NASDAQ: TRNS): 11/5/2026 – Transcat was upgraded by Zacks Research from “hold” to “strong-buy”. 11/4/2026 – Transcat was upgraded by Oppenheimer from “market perform” to “outperform”. They now have a $115.00 price target on the stock. 10/27/2026 – Transcat is now covered by […]
Avidbank (AVBH) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Avidbank (NASDAQ: AVBH) in the last few weeks: 10/29/2026 – Avidbank was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”. 10/29/2026 – Avidbank had its price target raised by Piper Sandler from $40.00 to $45.00. They now have an “overweight” rating […]
Analysts’ Recent Ratings Updates for AtriCure (ATRC)
A number of research firms have changed their ratings and price targets for AtriCure (NASDAQ: ATRC): 11/4/2026 – AtriCure had its price target raised by BTIG Research from $63.00 to $70.00. They now have a “buy” rating on the stock. 11/4/2026 – AtriCure was upgraded by Zacks Research from “hold” to “strong-buy”. 11/4/2026 – AtriCure […]
Eastern Bankshares (EBC) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Eastern Bankshares (NASDAQ: EBC) in the last few weeks: 11/3/2026 – Eastern Bankshares had its price target raised by Barclays from $23.00 to $24.00. They now have an “equal weight” rating on the stock. 11/2/2026 – Eastern Bankshares was upgraded by Weiss Ratings […]
Recent Research Analysts’ Ratings Updates for Sandvik (SDVKY)
Sandvik (OTCMKTS: SDVKY) has recently received a number of price target changes and ratings updates: 10/23/2026 – Sandvik was upgraded by Nordea Equity Research from “hold” to “buy”. 10/23/2026 – Sandvik was upgraded by Zacks Research from “hold” to “strong-buy”. 10/22/2026 – Sandvik was upgraded by Pareto Securities from “hold” to “buy”. 10/19/2026 – Sandvik […]
Recent Analysts’ Ratings Updates for Kinder Morgan (KMI)
Kinder Morgan (NYSE: KMI) recently received a number of ratings updates from brokerages and research firms: 11/3/2026 – Kinder Morgan had its price target lowered by Morgan Stanley from $40.00 to $39.00. They now have an “equal weight” rating on the stock. 11/2/2026 – Kinder Morgan had its price target raised by JPMorgan Chase & […]
American Tower (AMT) – Research Analysts’ Recent Ratings Updates
American Tower (NYSE: AMT) has recently received a number of price target changes and ratings updates: 10/30/2026 – American Tower had its price target raised by Truist Financial from $207.00 to $210.00. They now have a “buy” rating on the stock. 10/28/2026 – American Tower had its “outperform” rating reaffirmed by Royal Bank Of Canada. […]
Analysts’ Recent Ratings Updates for Illumina (ILMN)
A number of research firms have changed their ratings and price targets for Illumina (NASDAQ: ILMN): 11/2/2026 – Illumina was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”. 11/2/2026 – Illumina had its price target raised by Citigroup from $113.00 to $210.00. They now have a “sell” rating on the stock. 10/30/2026 – […]
Research Analysts’ Recent Ratings Updates for ONEOK (OKE)
A number of firms have modified their ratings and price targets on shares of ONEOK (NYSE: OKE) recently: 11/3/2026 – ONEOK had its price target raised by Scotiabank from $96.00 to $97.00. They now have a “sector perform” rating on the stock. 11/2/2026 – ONEOK had its price target raised by Freedom Broker from $105.00 […]
Recent Analysts’ Ratings Updates for United Therapeutics (UTHR)
Several analysts have recently updated their ratings and price targets for United Therapeutics (NASDAQ: UTHR): 10/28/2026 – United Therapeutics had its price target lowered by JPMorgan Chase & Co. from $710.00 to $695.00. They now have an “overweight” rating on the stock. 10/26/2026 – United Therapeutics had its “overweight” rating reaffirmed by Cantor Fitzgerald. They […]
Recent Analysts’ Ratings Updates for General Motors (GM)
A number of research firms have changed their ratings and price targets for General Motors (NYSE: GM): 10/30/2026 – General Motors was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”. 10/28/2026 – General Motors had its price target raised by Tigress Financial from $130.00 to $132.00. They now have a “strong-buy” rating on […]
Recent Research Analysts’ Ratings Updates for AngloGold Ashanti (AU)
AngloGold Ashanti (NYSE: AU) has recently received a number of price target changes and ratings updates: 11/2/2026 – AngloGold Ashanti is now covered by TD Cowen. They set a “buy” rating and a $123.00 price target on the stock. 10/30/2026 – AngloGold Ashanti had its price target lowered by JPMorgan Chase & Co. from $139.00 […]
Analysts’ Recent Ratings Updates for Centrus Energy (LEU)
A number of research firms have changed their ratings and price targets for Centrus Energy (NYSE: LEU): 10/28/2026 – Centrus Energy had its price target lowered by B. Riley Financial from $295.00 to $188.00. They now have a “buy” rating on the stock. 10/27/2026 – Centrus Energy was given a new $151.00 price target by […]
Analysts’ Recent Ratings Updates for MaxLinear (MXL)
Several analysts have recently updated their ratings and price targets for MaxLinear (NASDAQ: MXL): 10/28/2026 – MaxLinear was upgraded by Zacks Research from “hold” to “strong-buy”. 10/23/2026 – MaxLinear was given a new $70.00 price target by Susquehanna. 10/20/2026 – MaxLinear had its price target lowered by Wells Fargo & Company from $95.00 to $78.00. […]
last updated on 16 Nov 20:22